These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32452075)

  • 1. Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy.
    Merlo M; Cannatà A; Pio Loco C; Stolfo D; Barbati G; Artico J; Gentile P; De Paris V; Ramani F; Zecchin M; Gigli M; Pinamonti B; Korcova R; Di Lenarda A; Giacca M; Mestroni L; Camici PG; Sinagra G
    Eur J Heart Fail; 2020 Jul; 22(7):1111-1121. PubMed ID: 32452075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy.
    Cannatà A; Fabris E; Merlo M; Artico J; Gentile P; Pio Loco C; Ballaben A; Ramani F; Barbati G; Sinagra G
    Can J Cardiol; 2020 Jan; 36(1):37-44. PubMed ID: 31515085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathy.
    Lalario A; Del Mestre E; Lo Casto M; Nuzzi V; Manca P; Bromage DI; Barbati G; Merlo M; Sinagra G; Cannatà A
    ESC Heart Fail; 2022 Oct; 9(5):3052-3059. PubMed ID: 35735911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Ischaemic and Dilated Cardiomyopathy on Short-Term and Long-Term Survival After Ventricular Assist Device Implantation: A Single-Centre Experience.
    Ivanov B; Djordjevic I; Sabashnikov A; Sindhu D; Hink S; Eghbalzadeh K; Gerfer S; Gaisendrees C; Schlachtenberger G; Rustenbach C; Seuthe K; Regnier K; Mader N; Pfister R; Zeriouh M; Rahmanian P; Wahlers T
    Heart Lung Circ; 2022 Mar; 31(3):383-389. PubMed ID: 34598889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural History of Dilated Cardiomyopathy in Children.
    Puggia I; Merlo M; Barbati G; Rowland TJ; Stolfo D; Gigli M; Ramani F; Di Lenarda A; Mestroni L; Sinagra G
    J Am Heart Assoc; 2016 Jun; 5(7):. PubMed ID: 27364989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability and performance of heart failure prognostic scores in dilated cardiomyopathy: the real-world experience of an Italian referral center for cardiomyopathies.
    Masè M; Rossi M; Setti M; Barbati G; Teso MV; Ribichini FL; Koni M; Stolfo D; Merlo M; Sinagra G
    Int J Cardiol; 2024 Feb; 396():131562. PubMed ID: 37907097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of pediatric patients with dilated cardiomyopathy listed for transplant: a multi-institutional study.
    Kirk R; Naftel D; Hoffman TM; Almond C; Boyle G; Caldwell RL; Kirklin JK; White K; Dipchand AI;
    J Heart Lung Transplant; 2009 Dec; 28(12):1322-8. PubMed ID: 19782601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.
    Merlo M; Pivetta A; Pinamonti B; Stolfo D; Zecchin M; Barbati G; Di Lenarda A; Sinagra G
    Eur J Heart Fail; 2014 Mar; 16(3):317-24. PubMed ID: 24464640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
    Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
    Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends in outcome and patient characteristics in dilated cardiomyopathy, data from the Swedish Heart Failure Registry 2003-2015.
    Sjöland H; Silverdal J; Bollano E; Pivodic A; Dahlström U; Fu M
    BMC Cardiovasc Disord; 2021 Jun; 21(1):307. PubMed ID: 34144681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, causes, and outcomes of dilated cardiomyopathy in children.
    Towbin JA; Lowe AM; Colan SD; Sleeper LA; Orav EJ; Clunie S; Messere J; Cox GF; Lurie PR; Hsu D; Canter C; Wilkinson JD; Lipshultz SE
    JAMA; 2006 Oct; 296(15):1867-76. PubMed ID: 17047217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry.
    Aleksova A; Sabbadini G; Merlo M; Pinamonti B; Barbati G; Zecchin M; Bussani R; Silvestri F; Iorio AM; Stolfo D; Dal Ferro M; Dragos AM; Meringolo G; Pyxaras S; Lo Giudice F; Perkan A; di Lenarda A; Sinagra G
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):699-705. PubMed ID: 19474760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current perspectives on the diagnosis and management of dilated cardiomyopathy Beyond heart failure: a Cardiomyopathy Clinic Doctor's point of view.
    Bakalakos A; Ritsatos K; Anastasakis A
    Hellenic J Cardiol; 2018; 59(5):254-261. PubMed ID: 29807197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into mildly dilated cardiomyopathy: temporal evolution and long-term prognosis.
    Gigli M; Stolfo D; Merlo M; Barbati G; Ramani F; Brun F; Pinamonti B; Sinagra G
    Eur J Heart Fail; 2017 Apr; 19(4):531-539. PubMed ID: 27813212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Pathogenic Gene Mutations and Prognosis Do Not Differ in Isolated Left Ventricular Dysfunction Compared With Dilated Cardiomyopathy.
    Hazebroek MR; Krapels I; Verdonschot J; van den Wijngaard A; Vanhoutte E; Hoos M; Snijders L; van Montfort L; Witjens M; Dennert R; Crijns HJGM; Brunner-La Rocca HP; Brunner HG; Heymans S
    Circ Heart Fail; 2018 Mar; 11(3):e004682. PubMed ID: 29540472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy.
    Halliday BP; Gulati A; Ali A; Newsome S; Lota A; Tayal U; Vassiliou VS; Arzanauskaite M; Izgi C; Krishnathasan K; Singhal A; Chiew K; Gregson J; Frenneaux MP; Cook SA; Pennell DJ; Collins P; Cleland JGF; Prasad SK
    Eur J Heart Fail; 2018 Oct; 20(10):1392-1400. PubMed ID: 29862606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilated cardiomyopathy in a pediatric population: etiology and outcome predictors - a single-center experience.
    Ciuca C; Ragni L; Hasan T; Balducci A; Angeli E; Prandstraller D; Egidy-Assenza G; Donti A; Bonvicini M; Gargiulo GD
    Future Cardiol; 2019 Mar; 15(2):95-107. PubMed ID: 30848673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and prognostic relevance of myocardial inflammation and cardiotropic viruses in non-ischemic dilated cardiomyopathy.
    Kažukauskienė I; Baltrūnienė V; Jakubauskas A; Žurauskas E; Maneikienė VV; Daunoravičius D; Čelutkienė J; Ručinskas K; Grabauskienė V
    Cardiol J; 2022; 29(3):441-453. PubMed ID: 32567670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.